Academic Journal

Aerosol Delivery With a Vibrating Mesh Nebulizer Across Tidal Volume-Based Pediatric Invasive Ventilation Models: An In Vitro Evaluation.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Aerosol Delivery With a Vibrating Mesh Nebulizer Across Tidal Volume-Based Pediatric Invasive Ventilation Models: An In Vitro Evaluation.
Συγγραφείς: Miura S; Division of Pediatric Critical Care, Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Japan., Igarashi Y; Department of Clinical Engineering, St. Marianna University Hospital, Kawasaki, Japan., Shono K; Division of Pediatric Critical Care, Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Japan., Shima S; Division of Pediatric Critical Care, Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Japan., Kawaguchi A; Division of Pediatric Critical Care, Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Japan.
Πηγή: Critical care explorations [Crit Care Explor] 2026 Jun 04; Vol. 8 (6), pp. e1430. Date of Electronic Publication: 2026 Jun 04 (Print Publication: 2026).
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101746347 Publication Model: eCollection Cited Medium: Internet ISSN: 2639-8028 (Electronic) Linking ISSN: 26398028 NLM ISO Abbreviation: Crit Care Explor Subsets: MEDLINE
Imprint Name(s): Original Publication: Philadelphia, PA : Wolters Kluwer Health, [2019]-
Ιατρικοί όροι (MeSH): Albuterol*/administration & dosage , Tidal Volume*/physiology , Respiration, Artificial*/methods , Respiration, Artificial*/instrumentation , Bronchodilator Agents*/administration & dosage , Nebulizers and Vaporizers*, Aerosols/administration & dosage ; Humans ; Child ; Administration, Inhalation ; Equipment Design
Περίληψη: Context: Despite the widespread use of vibrating mesh nebulizers (VMNs) for aerosol therapy during mechanical ventilation, there is limited pediatric evidence on how tidal volume (TV)-based ventilation models and commonly modified ventilator- and circuit-related factors affect aerosol delivery.
Hypothesis: We hypothesized that these ventilator- and circuit-related modifications would affect the efficacy of aerosol delivery with a VMN.
Methods and Models: We conducted an in vitro experiment using six pediatric ventilation models with TVs set at 8 mL/kg (TV: 40-400 mL for 5-50 kg), representing children from infancy to adolescence. We nebulized salbutamol with a VMN positioned on the dry side of a heated humidifier, and quantified inhaled mass fraction by measuring the drug collected on a filter positioned distal to the endotracheal tube using a spectrophotometer. We evaluated the effects of TV-based models and variations in other settings, including endotracheal tube sizes, bias flows, inspiratory rise time, ventilator modes, circuit configurations, VMN positions, and drug concentrations.
Results: In the baseline model with a TV of 80 mL, the mean ± sd of inhaled mass fraction was 11.2% ± 0.3%. It increased progressively across the TV-based models: 3.5% ± 0.2% (TV: 40 mL), 7.9% ± 0.4% (TV: 56 mL), 15.7% ± 0.2% (TV: 120 mL), 19.4% ± 0.4% (TV: 160 mL), and 21.3% ± 1.7% (TV: 400 mL; all p < 0.001 vs. baseline). No significant differences were observed in variations of the other ventilatory, endotracheal tube-, or circuit-related settings.
Interpretation and Conclusions: VMN aerosol delivery increased across TV-based ventilation models and was minimally affected by other ventilator settings, endotracheal tube size, and circuit-related modifications. Consistent aerosol delivery at a given TV suggests that TV is the dominant determinant of aerosol delivery efficacy.
(Copyright © 2026 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.)
Competing Interests: Drs. Shono and Kawaguchi received provision of experimental equipment from Fisher & Paykel Healthcare and Aerogen for use in other research projects. The remaining authors have disclosed that they do not have any potential conflicts of interest.
References: J Aerosol Med Pulm Drug Deliv. 2015 Jun;28(3):229-36. (PMID: 25393556)
Respir Care. 2017 Jun;62(6):662-677. (PMID: 28546371)
Respir Care. 2013 Jul;58(7):1124-33. (PMID: 23107173)
Am J Respir Crit Care Med. 2003 Nov 15;168(10):1205-9. (PMID: 12893644)
Ann Intensive Care. 2023 Jul 12;13(1):63. (PMID: 37436585)
Respir Care. 2010 Jul;55(7):845-51. (PMID: 20587095)
Intensive Care Med. 2003 Jul;29(7):1145-50. (PMID: 12750882)
J Aerosol Med Pulm Drug Deliv. 2017 Oct;30(5):349-358. (PMID: 28463044)
Respir Care. 2018 Nov;63(11):1370-1378. (PMID: 30108135)
Respir Med. 2023 May;211:107210. (PMID: 36907367)
Respir Care. 2014 Oct;59(10):1494-500. (PMID: 24865422)
Respir Care. 2015 Jun;60(6):894-914; discussion 914-6. (PMID: 26070582)
Respir Care. 2020 Oct;65(10):1419-1426. (PMID: 32694180)
Respir Care. 2015 Oct;60(10):1424-30. (PMID: 25969513)
Can J Respir Ther. 2022 Dec 16;58:199-203. (PMID: 36545463)
Crit Care. 2000;4(4):227-34. (PMID: 11094505)
Contributed Indexing: Keywords: aerosol therapy; mechanical ventilation; pediatric; tidal volume; vibrating mesh nebulizer
Substance Nomenclature: QF8SVZ843E (Albuterol)
0 (Aerosols)
0 (Bronchodilator Agents)
Entry Date(s): Date Created: 20260608 Date Completed: 20260611 Latest Revision: 20260813
Update Code: 20260813
PubMed Central ID: PMC13236288
DOI: 10.1097/CCE.0000000000001430
PMID: 42255941
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:2639-8028
DOI:10.1097/CCE.0000000000001430